Disturbances of anticoagulation and fibrinolytic systems in monoclonal gammopathies—another mechanism of M-protein interference with hemostasis

Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant.

Perumal Thiagarajan, Sandor S. Shapiro, Luigi De Marco · Journal of Clinical Investigation · 1980 · 363 citations · Full text

Medicine, Biochemistry, Hematology +17

Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy

Maurizio Zangari, Eric R. Siegel, Bart Barlogie et al. · Blood · 2002 · 263 citations

Medicine, Hematology, Pharmacology +14

The prethrombotic state in cancer.

Guido Luzzatto, Schafer Ai · PubMed · 1990 · 163 citations

Medicine, Cancer Biology, Oncology +10

Hemostatic Defects in Dysproteinemias

Herbert A. Perkins, Malcolm R. MacKenzie, H. Hugh Fudenberg · Blood · 1970 · 161 citations · Full text

Medicine, Genetics, Hematology +12

Actiated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications

Maurizio Zangari, Fariba Saghafifar, E. Anaissie et al. · Blood Coagulation & Fibrinolysis · 2002 · 137 citations

Medicine, Hematology, Oncology +17